The weight-loss jab Wegovy may help people quit smoking, researchers suggest. Smokers with type 2 diabetes who took semaglutide were less likely to need medical care linked to their smoking, a study found. Researchers said the findings indicate the drug, sold under the brand name Wegovy, should be investigated for its use in helping people stop smoking. Compared to seven other diabetes medications, using semaglutide was associated with a lower risk for medical care related to tobacco addiction (tobacco use disorder – TUD), the study found. Those who used the drug were less likely to be diagnosed with TUD, be prescribed medication to stop smoking or be given smoking cessation counselling. In the journal Annals of Internal Medicine the researchers said: “Semaglutide was associated with reduced smoking cessation medication prescriptions and counselling. “Similar findings were observed in patients with and without a diagnosis of obesity.” They added: “These findings suggest the need for clinical trials to evaluate semaglutide’s potential for TUD treatment.” Read more:Jab approved for use in preventing heart attacks and strokesWhat are weight …